|
1
|
Fidelity Investments
Boston,
Massachusetts
|
$316M
|
-$16M
|
-184,520
|
-5%
|
|
|
2
|
Palo Alto Investors
Palo Alto,
California
|
$286M
|
+$61.2M
|
+707,691
|
+29%
|
|
|
3
|
PFM Health Sciences
San Francisco,
California
|
$235M
|
-$13.9M
|
-160,774
|
-6%
|
|
|
4
|
Vanguard Group
Malvern,
Pennsylvania
|
$190M
|
+$22.9M
|
+264,515
|
+15%
|
|
|
5
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$178M
|
-$25M
|
-288,764
|
-13%
|
|
|
6
|
OppenheimerFunds
New York
|
$124M
|
-$14.7M
|
-169,580
|
-11%
|
|
|
7
|
Antipodean Advisors
New York
|
$120M
|
+$113M
|
+1,306,491
|
New
|
|
|
8
|
BlackRock Fund Advisors
San Francisco,
California
|
$114M
|
+$17M
|
+196,771
|
+19%
|
|
|
9
|
NEA Management Company
Timonium,
Maryland
|
$105M
|
–
|
–
|
–
|
|
|
10
|
|
$102M
|
+$8.71M
|
+100,700
|
+10%
|
|
|
11
|
Redmile Group
San Francisco,
California
|
$88.1M
|
+$17.1M
|
+198,155
|
+26%
|
|
|
12
|
Clifton Park Capital Management
Wilmington,
Delaware
|
$81.2M
|
+$4.84M
|
+55,972
|
+7%
|
|
|
13
|
Viking Global Investors
Stamford,
Connecticut
|
$76.9M
|
+$72.4M
|
+836,332
|
New
|
|
|
14
|
Visium Asset Management
New York
|
$71.9M
|
+$2.68M
|
+30,955
|
+4%
|
|
|
15
|
BlackRock Institutional Trust
San Francisco,
California
|
$69.6M
|
+$5.69M
|
+65,779
|
+10%
|
|
|
16
|
State Street
Boston,
Massachusetts
|
$67.3M
|
+$2.24M
|
+25,886
|
+4%
|
|
|
17
|
Wells Fargo
San Francisco,
California
|
$58.4M
|
+$52.5M
|
+606,464
|
+2,083%
|
|
|
18
|
Citadel Advisors
Miami,
Florida
|
$58.1M
|
+$12.9M
|
+149,282
|
+31%
|
|
|
19
|
BB Biotech
Schaffhausen,
Switzerland
|
$56.8M
|
–
|
–
|
–
|
|
|
20
|
Balyasny Asset Management
Chicago,
Illinois
|
$44.4M
|
+$36.1M
|
+417,381
|
+633%
|
|
|
21
|
TimesSquare Capital Management
New York
|
$38.5M
|
-$6.2M
|
-71,595
|
-15%
|
|
|
22
|
Versant Venture Management
San Francisco,
California
|
$37.5M
|
–
|
–
|
–
|
|
|
23
|
|
$31.9M
|
+$13.5M
|
+155,736
|
+81%
|
|
|
24
|
Northern Trust
Chicago,
Illinois
|
$29.9M
|
+$3.28M
|
+37,937
|
+13%
|
|
|
25
|
|
$29.9M
|
+$975K
|
+11,268
|
+4%
|
|
